Fr. 297.00

Cannabinoids as Therapeutics

English · Hardback

Shipping usually within 6 to 7 weeks

Description

Read more

In recent years, cannabis research has concentrated on the potential of cannabinoids as therapeutic substances, particularly in serious chronic illnesses such as multiple sclerosis. Most volumes published on cannabinoids so far concentrate on the biological activity, biochemistry and pharmacology, whereas this volume concentrates on the diseases, the physiological effects and therapeutic use of cannabinoids. The volume editor Prof. Mechoulam was the first who isolated the prime active constituent (THC, Tetrahydrocannabiol) of marijuana. He published extensively on the pharmacological activities of cannabinoids. The volume is of interest to researchers and clinicians from pharmacology, neuroscience, and medicinal research.

List of contents

Cannabis in India: ancient lore and modern medicine.- Cannabinoid chemistry: an overview.- Cannabidiol as a potential medicine.- Endocannabinoids and regulation of fertility.- Cannabinoids in neurodegeneration and neuroprotection.- Role of the endocannabinoid system in learning and memory.- Cannabinoids and anxiety.- Cannabinoid targets for pain therapeutics.- Potential use of cannabimimetics in the treatment of cancer.- Cannabinoids: effects on vomiting and nausea in animal models.- The skeleton: stone bones and stoned heads?.- Cannabinoids and drugs of abuse.- Cannabinoids in appetite and obesity.- The development of Sativex® - a natural cannabis-based medicine.

Summary

In recent years, cannabis research has concentrated on the potential of cannabinoids as therapeutic substances, particularly in serious chronic illnesses such as multiple sclerosis. Most volumes published on cannabinoids so far concentrate on the biological activity, biochemistry and pharmacology, whereas this volume concentrates on the diseases, the physiological effects and therapeutic use of cannabinoids. The volume editor Prof. Mechoulam was the first who isolated the prime active constituent (THC, Tetrahydrocannabiol) of marijuana. He published extensively on the pharmacological activities of cannabinoids. The volume is of interest to researchers and clinicians from pharmacology, neuroscience, and medicinal research.

Product details

Assisted by R. Mechoulam (Editor), Raphae Mechoulam (Editor), Raphael Mechoulam (Editor)
Publisher Springer, Basel
 
Languages English
Product format Hardback
Released 27.05.2005
 
EAN 9783764370558
ISBN 978-3-7643-7055-8
No. of pages 268
Dimensions 175 mm x 245 mm x 22 mm
Weight 644 g
Illustrations X, 268 p.
Series Milestones in Drug Therapy
Milestones in Drug Therapy
Subjects Natural sciences, medicine, IT, technology > Medicine > Pharmacy

Physiologie, Psychiatrie, B, Neurologie und klinische Neurophysiologie, Neurowissenschaften, Research, Neurology, HUMAN PHYSIOLOGY, PHYSIOLOGY, Neuroscience, Psychiatry, Obesity, Neurology & clinical neurophysiology, Neurosciences, Pharmacology, Rheumatoid arthritis, Biomedical and Life Sciences, Pharmacology/Toxicology

Customer reviews

No reviews have been written for this item yet. Write the first review and be helpful to other users when they decide on a purchase.

Write a review

Thumbs up or thumbs down? Write your own review.

For messages to CeDe.ch please use the contact form.

The input fields marked * are obligatory

By submitting this form you agree to our data privacy statement.